Trials / Completed
CompletedNCT00931476
A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin
A Single-centre, Randomised, Double-blind, Placebo-controlled, Parallel Group, Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Norditropin® (Norditropin® PenSet® 24)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This trial was conducted in the United States of America (USA). The aim of this clinical trial was to investigate the pharmacokinetics of somatropin in healthy Japanese and Caucasian subjects, and to identify somatostatin-related adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin | |
| DRUG | placebo |
Timeline
- Start date
- 2000-04-06
- Primary completion
- 2000-06-08
- Completion
- 2000-06-08
- First posted
- 2009-07-02
- Last updated
- 2017-02-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00931476. Inclusion in this directory is not an endorsement.